BioNTech, Ryvu collaborate on small molecule immuno-modulatory therapies

By NS Healthcare Staff Writer

01 Dec 22

Under the collaboration, the two companies will jointly develop several small molecule programmes, primarily targeting immune modulation in…

PharmaceuticalsDrug discovery

UK announces over £800m funding to improve innovation, growth and patient safety

By NS Healthcare Staff Writer

17 Oct 22

The funding will help to generate new treatments and improve the delivery of healthcare services to support experimental…

PharmaceuticalsDrug discovery

Odyssey Therapeutics secures $168m in Series B financing round

By NS Healthcare Staff Writer

14 Oct 22

The new financing will allow Odyssey Therapeutics to advance its portfolio of precision immunomodulators and oncology medicines, supporting…

PharmaceuticalsDrug discovery

Illumina, AstraZeneca collaborate on drug target discovery

By NS Healthcare Staff Writer

12 Oct 22

The strategic research collaboration will combine Illumina and AstraZeneca’s combined strengths in artificial intelligence (AI) based genome interpretation…

PharmaceuticalsDrug discovery

CytoReason, Pfizer sign $110m extended AI-based drug development deal

By NS Healthcare Staff Writer

21 Sep 22

Pfizer has used CytoReason's biological models in its research to improve the understanding of the immune system and…

PharmaceuticalsDrug discovery

Valo Health acquires TARA Biosystems to create integrated cardiovascular platform

By NS Healthcare Staff Writer

07 Apr 22

The transaction will create a vertically integrated platform and cardiovascular disease franchise, which will support the discovery and…

PharmaceuticalsDrug discovery

Exscientia, Oxford TDI partner for Xcellomics drug discovery programme

By NS Healthcare Staff Writer

11 Mar 22

Xcellomics programme was created by the two Oxford-based institutions to advance the early-stage drug discovery research by academic…

PharmaceuticalsDrug discovery

Pfizer extends collaboration with Israeli tech start-up CytoReason

By NS Healthcare Staff Writer

11 Feb 22

The US drugmaker has used several insights from the CytoReason’ platform, in several of its R&D programmes across…

PharmaceuticalsDrug discovery

Ventus Therapeutics raises $140m to advance drug discovery platform

By NS Healthcare Staff Writer

10 Feb 22

The investment round, jointly led by SoftBank Vision Fund 2 and RA Capital Management, will advance the company’s…

Patient CarePharmaceuticals and MedicinesDrug discovery

Novartis to acquire Gyroscope Therapeutics for up to $1.5bn

By NS Healthcare Staff Writer

23 Dec 21

The acquisition will enable Novartis to add Gyroscope’s investigational gene therapy, GT005, to its portfolio

PharmaceuticalsDrug discovery